Trials / Completed
CompletedNCT04176224
Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis
Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Tanabe Pharma Corporation · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the pharmacokinetics of single doses of edaravone oral suspension in Patients with Amyotrophic Lateral Sclerosis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MT-1186 | Suspension |
Timeline
- Start date
- 2019-04-17
- Primary completion
- 2019-09-04
- Completion
- 2019-09-04
- First posted
- 2019-11-25
- Last updated
- 2026-01-07
- Results posted
- 2024-01-24
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04176224. Inclusion in this directory is not an endorsement.